Research at Queen'sQueen’s Partnerships and Innovation is pleased to report the issuance of Canadian Patent No. 3,093,373 "N-Acylated Hyaluronic Acid for Hyperuricemia and Gouty Arthritis" on February 10, 2026 to Yin Gao and Tassos Anastassiades. The patent relates to hyaluronic acid derivatives and in particular, derivatives in which the N-acetyl group of hyaluronic has been substituted, and methods and uses therof.